Spots Global Cancer Trial Database for solid malignancy
Every month we try and update this database with for solid malignancy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Geriatric Oncology Surgical Assessment and Functional rEcovery After Surgery | NCT03299270 | Elderly Solid Malignanc... | Questionnaires | 70 Years - | AUSL Romagna Rimini | |
Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain | NCT01846429 | Tumor Cancer Pain Malignant Solid... Unresectable Ma... Hematologic Mal... Multiple Myelom... Lymphoma Neoplasm Metast... | Sodium Bicarbon... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies | NCT06208878 | Hematologic Mal... Solid Malignanc... | Non Interventio... | 18 Years - | CRISPR Therapeutics | |
Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain | NCT01846429 | Tumor Cancer Pain Malignant Solid... Unresectable Ma... Hematologic Mal... Multiple Myelom... Lymphoma Neoplasm Metast... | Sodium Bicarbon... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer | NCT02922764 | Endometrial Can... Endometrial Can... Lung Cancer Rec... Lung Cancer Non-small Cell ... Non-small Cell ... | RGX-104 Ipilimumab Docetaxel Pembrolizumab Carboplatin Pemetrexed | 18 Years - | Inspirna, Inc. | |
Geriatric Oncology Surgical Assessment and Functional rEcovery After Surgery | NCT03299270 | Elderly Solid Malignanc... | Questionnaires | 70 Years - | AUSL Romagna Rimini | |
Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations | NCT02352844 | Solid Malignanc... Solid Tumor | Everolimus | 18 Years - | Washington University School of Medicine | |
Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors | NCT01165905 | Solid Tumor | ON 01910.Na Gemcitabine | 18 Years - | Traws Pharma, Inc. | |
Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations | NCT02352844 | Solid Malignanc... Solid Tumor | Everolimus | 18 Years - | Washington University School of Medicine | |
PET Imaging of Subjects Using 124I-PU-AD | NCT03371420 | Lymphoma Solid Malignanc... Alzheimer Disea... Myeloma | PU-AD PET Scan Blood Draws | 21 Years - 90 Years | Samus Therapeutics, Inc. | |
PET Imaging of Subjects Using 124I-PU-AD | NCT03371420 | Lymphoma Solid Malignanc... Alzheimer Disea... Myeloma | PU-AD PET Scan Blood Draws | 21 Years - 90 Years | Samus Therapeutics, Inc. | |
Geriatric Oncology Surgical Assessment and Functional rEcovery After Surgery | NCT03299270 | Elderly Solid Malignanc... | Questionnaires | 70 Years - | AUSL Romagna Rimini | |
A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R) | NCT01697930 | Solid Malignanc... Lymphoma | [18F] 4-L-Fluor... | 21 Years - 90 Years | Memorial Sloan Kettering Cancer Center |